Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
World J Gastroenterol. 2024 Mar 14;30(10):1291-1294. doi: 10.3748/wjg.v30.i10.1291.
In recent years, endoscopic resection, particularly endoscopic submucosal dissection, has become increasingly popular in treating non-metastatic superficial esophageal squamous cell carcinoma (ESCC). In this evolving paradigm, it is crucial to identify factors that predict higher rates of lymphatic invasion and poorer outcomes. Larger tumor size, deeper invasion, poorer differentiation, more infiltrative growth patterns (INF-c), higher-grade tumor budding, positive lymphovascular invasion, and certain biomarkers have been associated with lymph node metastasis and increased morbidity through retrospective reviews, leading to the construction of comprehensive nomograms for outcome prediction. If validated by future prospective studies, these nomograms would prove highly applicable in guiding the selection of treatment for superficial ESCC.
近年来,内镜切除术,特别是内镜黏膜下剥离术,在治疗非转移性浅表性食管鳞状细胞癌(ESCC)中越来越受欢迎。在这一不断发展的模式中,识别预测更高的淋巴侵袭率和更差的预后的因素至关重要。通过回顾性研究发现,较大的肿瘤大小、更深的浸润、较差的分化、更具浸润性生长模式(INF-c)、较高等级的肿瘤芽生、阳性淋巴管浸润以及某些生物标志物与淋巴结转移和增加的发病率相关,并构建了用于预测结果的综合列线图。如果未来的前瞻性研究得到验证,这些列线图将非常适用于指导浅表性 ESCC 的治疗选择。